Sumitovant has acquired all outstanding shares of Myovant not already owned by Sumitovant in an all-cash deal valued at $1.7 billion.
Intelligence for the Dealmaking Community since 1965
After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.